Propanc Biopharma (PPCB) Short Interest Ratio & Short Volume $4.00 +0.99 (+32.89%) As of 03:57 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Propanc Biopharma Short Interest DataPropanc Biopharma (PPCB) has a short interest of 200 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 815 shares to cover all short positions.Current Short Interest200 sharesPrevious Short Interest200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$979.12Short Interest Ratio0.1 Days to CoverLast Record DateApril 15, 2025Outstanding Shares19,000 sharesShort Percent of Float0.00%Today's Trading Volume962 sharesAverage Trading Volume815 sharesToday's Volume Vs. Average118% Short Selling Propanc Biopharma? Sign up to receive the latest short interest report for Propanc Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPPCB Short Interest Over TimePPCB Days to Cover Over TimePPCB Percentage of Float Shorted Over Time Propanc Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025200 shares $979.12 No Change0.0%0.1 $4.90 3/31/2025200 shares $1,100.00 No Change0.0%0.3 $5.50 3/15/2025200 shares $1,350.00 +100.0%0.0%0.5 $6.75 2/28/2025100 shares $675.00 No Change0.0%0.1 $6.75 1/15/202532,200 shares $9.66 No ChangeN/A0 $0.00 10/31/202492,900 shares $27.87 No ChangeN/A0 $0.00 9/30/20241,578,600 shares $473.58 -16.2%N/A0.1 $0.00 9/15/20241,884,500 shares $753.80 +21.6%N/A0.3 $0.00 8/31/20241,550,100 shares $620.04 -46.4%N/A0.1 $0.00 8/15/20242,893,800 shares $1,157.52 +1,784.0%N/A0 $0.00 Get the Latest News and Ratings for PPCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024153,600 shares $122.88 No ChangeN/A0 $0.00 6/30/202431,500 shares $39.38 -57.2%N/A0 $0.00 6/15/202473,600 shares $117.76 No ChangeN/A0 $0.00 5/15/202477,600 shares $54.32 +9.8%N/A0 $0.00 4/30/202470,700 shares $70.70 No ChangeN/A0 $0.00 3/31/20246,200 shares $19.84 No ChangeN/A0 $0.00 2/29/2024127,100 shares $432.14 +355.6%N/A0 $0.00 2/15/202427,900 shares $131.13 +39.5%N/A0 $0.00 1/15/202412,000 shares $120.00 +11,900.0%N/A0 $0.01 12/31/2023100 shares $1.20 -99.8%N/A0 $0.01 12/15/202359,300 shares $646.37 +352.7%N/A0 $0.01 11/30/202313,100 shares $111.35 +23.6%N/A0 $0.01 11/15/202310,600 shares $140.98 -74.9%N/A0 $0.01 10/31/202342,200 shares $481.08 +20.6%N/A0.1 $0.01 10/15/202335,000 shares $560.00 +18.2%N/A0 $0.02 9/30/202329,600 shares $722.24 +179.3%N/A0.1 $0.02 9/15/202310,600 shares $318.00 -64.7%N/A0 $0.03 8/31/202330,000 shares $1,647.00 No ChangeN/A0 $0.05 7/31/202334,000 shares $2,764.20 -5.0%N/A0 $0.08 7/15/202335,800 shares $3,377.73 +21.8%N/A0 $0.09 6/30/202329,400 shares $3,969.00 No ChangeN/A0 $0.14 5/15/2023310,100 shares $62,020.00 +310,000.0%N/A0 $0.20 4/30/2023100 shares $0.03 -99.5%N/A0 $0.00 4/15/202318,100 shares $5.43 -90.4%N/A0 $0.00 3/31/2023188,600 shares $94.30 +887.4%N/A0 $0.00 3/15/202319,100 shares $11.46 -39.2%N/A0 $0.00 2/28/202331,400 shares $21.98 -7.9%N/A0 $0.00 2/15/202334,100 shares $10.23 -76.3%N/A0 $0.00 1/31/2023144,000 shares $57.60 -28.0%N/A0 $0.00 1/15/2023200,100 shares $100.05 +200,000.0%N/A0 $0.00Elon Set to Shock the World by May 1st ? (Ad)Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX. Click here now because after June 1st, it could be too late. 12/30/2022100 shares $0.06 -99.8%N/A0 $0.00 12/15/202255,100 shares $33.06 -90.3%N/A0 $0.00 11/30/2022565,200 shares $395.64 +1,025.9%N/A0 $0.00 11/15/202250,200 shares $40.16 -49.9%N/A0 $0.00 10/31/2022100,200 shares $100.20 +57.8%N/A0 $0.00 10/15/202263,500 shares $76.20 -30.6%N/A0 $0.00 9/30/202291,500 shares $109.80 +45,650.0%N/A0 $0.00 9/15/2022200 shares $0.34 -99.3%N/A0 $0.00 8/31/202228,500 shares $54.15 -78.2%N/A0 $0.00 8/15/2022130,800 shares $300.84 +8.0%N/A0 $0.00 7/31/2022121,100 shares $399.63 -47.4%N/A0 $0.00 7/15/2022230,000 shares $575.00 +37.6%N/A0 $0.00 6/30/2022167,200 shares $618.64 +113.3%N/A0 $0.00 6/15/202278,400 shares $227.36 +27.7%N/A0 $0.00 5/31/202261,400 shares $466.64 +1,103.9%N/A0 $0.01 5/15/20225,100 shares $42.02 -70.5%N/A0 $0.01 4/30/202217,300 shares $193.76 -94.8%N/A0 $0.01 4/15/2022331,900 shares $3,949.61 +824.5%N/A0.1 $0.01 3/31/202235,900 shares $560.04 +32.0%N/A0 $0.02 3/15/202227,200 shares $367.20 -3.9%N/A0 $0.01 2/28/202228,300 shares $478.41 No ChangeN/A0 $0.02 1/31/202220,400 shares $393.72 No ChangeN/A0 $0.02 12/31/20213,400 shares $149.60 -83.2%N/A0 $0.04 12/15/202120,200 shares $466.62 No ChangeN/A0 $0.02 11/15/20213,800 shares $114.00 +11.8%N/A0 $0.03 10/29/20213,400 shares $99.28 +209.1%N/A0 $0.03 10/15/20211,100 shares $30.58 -94.8%N/A0 $0.03 9/30/202121,100 shares $548.60 No ChangeN/A0 $0.03 8/31/202125,000 shares $1,182.50 No ChangeN/A0 $0.05 7/30/202116,600 shares $595.94 +5.7%N/A0 $0.04 7/15/202115,700 shares $703.36 +17.2%N/A0 $0.04 6/30/202113,400 shares $692.78 -41.7%N/A0 $0.05 6/15/202123,000 shares $1,817.00 -60.8%N/A0 $0.08 5/28/202158,600 shares $4,688.00 +4,783.3%N/A0.1 $0.08 5/14/20211,200 shares $156.00 -75.0%N/A0 $0.13 4/30/20214,800 shares $1,034.40 +269.2%N/A0.1 $0.22 4/15/20211,300 shares $273.00 -74.0%N/A0 $0.21 3/31/20215,000 shares $1,252.00 -27.5%N/A0 $0.25 3/15/20216,900 shares $3,105.00 -60.1%N/A0.1 $0.45 2/26/202117,300 shares $5,017.00 -8.0%N/A0.1 $0.29 2/12/202118,800 shares $8,084.00 +2,250.0%N/A0 $0.43 1/29/2021800 shares $332.08 -75.8%N/A0 $0.42 12/31/20202,000 shares $620.00 No ChangeN/A0 $0.31 10/30/2020100 shares $0.17 No ChangeN/A0 $0.00 9/30/202084,100 shares $159.79 +188.0%N/A0 $0.00 9/15/202029,200 shares $52.56 +2,820.0%N/A0 $0.00 8/31/20201,000 shares $2.40 No ChangeN/A0 $0.00 7/15/202012,900 shares $34.83 No ChangeN/A0 $0.00 5/15/202013,700 shares $164.40 -74.6%N/A0 $0.01 PPCB Short Interest - Frequently Asked Questions What is Propanc Biopharma's current short interest? Short interest is the volume of Propanc Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 200 shares of PPCB short. 0.00% of Propanc Biopharma's shares are currently sold short. Learn More on Propanc Biopharma's current short interest. What is a good short interest percentage for Propanc Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Propanc Biopharma's floating shares are currently sold short. How does Propanc Biopharma's short interest compare to its competitors? 0.00% of Propanc Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Propanc Biopharma: Vincerx Pharma, Inc. (2.97%), Capstone Holding Corp. (0.11%), Virpax Pharmaceuticals, Inc. (26.21%), TFF Pharmaceuticals, Inc. (3.95%), TC Biopharm (Holdings) Plc (176.43%), GlobeStar Therapeutics Co. (0.00%), Aditxt, Inc. (1.68%), NovAccess Global Inc. (0.00%), American Bio Medica Co. (0.00%), and Novo Nordisk A/S (0.43%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Propanc Biopharma stock? Short selling PPCB is an investing strategy that aims to generate trading profit from Propanc Biopharma as its price is falling. PPCB shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Propanc Biopharma? A short squeeze for Propanc Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PPCB, which in turn drives the price of the stock up even further. How often is Propanc Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPCB, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Vincerx Pharma Short Interest Capstone Short Interest Virpax Pharmaceuticals Short Interest TFF Pharmaceuticals Short Interest TC Biopharm Short Interest GlobeStar Therapeutics Short Interest Aditxt Short Interest NovAccess Global Short Interest American Bio Medica Short Interest Novo Nordisk A/S Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PPCB) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Propanc Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Propanc Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PPCB Stock Free PPCB Stock Alerts